Related Experiment Video
Updated: Jun 24, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Venlafaxine in the treatment of panic disorder
Martin A Katzman1, Leslie Jacobs
1START Clinic for the Mood and Anxiety Disorders, 790 Bay, Street-Suite 900, Toronto, ON M5G 1N8, Canada. mkatzman@startclinic.ca
Abstract:
Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with continued treatment, venlafaxine is an important option to the SSRIs for the treatment of patients with panic disorder.
Related Concept Videos
Panic Disorder
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Anxiolytic Drugs: Benzodiazepines and Buspirone
Antidepressant Drugs: Overview
Electroconvulsive Therapy